Major Functional Transcriptome of an Inferred Center Regulator of an ER(-) Breast Cancer Model System
- PMID: 22553414
- PMCID: PMC3337785
- DOI: 10.4137/CIN.S8633
Major Functional Transcriptome of an Inferred Center Regulator of an ER(-) Breast Cancer Model System
Abstract
We aimed to find clinically relevant gene activities ruled by the signal transducer and activator of transcription 3 (STAT3) proteins in an ER(-) breast cancer population via network approach. STAT3 is negatively associated with both lymph nodal category and stage. MYC is a component of STAT3 network. MYC and STAT3 may co-regulate gene expressions for Warburg effect, stem cell like phenotype, cell proliferation and angiogenesis. We identified a STAT3 network in silico showing its ability in predicting its target gene expressions primarily for specific tumor subtype, tumor progression, treatment options and prognostic features. The aberrant expressions of MYC and STAT3 are enriched in triple negatives (TN). They promote histological grade, vascularity, metastasis and tumor anti-apoptotic activities. VEGFA, STAT3, FOXM1 and METAP2 are druggable targets. High levels of METAP2, MMP7, IGF2 and IGF2R are unfavorable prognostic factors. STAT3 is an inferred center regulator at early cancer development predominantly in TN.
Keywords: STAT3; grade; microarray; transcriptional regulatory network; vascularity.
Figures








Similar articles
-
Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system.Cancer Inform. 2014 Jan 21;13:21-45. doi: 10.4137/CIN.S12493. eCollection 2014. Cancer Inform. 2014. PMID: 24526833 Free PMC article.
-
SHCBP1 regulates STAT3/c-Myc signaling activation to promote tumor progression in penile cancer.Am J Cancer Res. 2020 Oct 1;10(10):3138-3156. eCollection 2020. Am J Cancer Res. 2020. PMID: 33163262 Free PMC article.
-
Genomic regulation of invasion by STAT3 in triple negative breast cancer.Oncotarget. 2017 Jan 31;8(5):8226-8238. doi: 10.18632/oncotarget.14153. Oncotarget. 2017. PMID: 28030809 Free PMC article.
-
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review.J Exp Clin Cancer Res. 2019 May 14;38(1):195. doi: 10.1186/s13046-019-1206-z. J Exp Clin Cancer Res. 2019. PMID: 31088482 Free PMC article.
-
Constitutive activation of STAT3 in breast cancer cells: A review.Int J Cancer. 2016 Jun 1;138(11):2570-8. doi: 10.1002/ijc.29923. Epub 2015 Nov 28. Int J Cancer. 2016. PMID: 26559373 Free PMC article. Review.
Cited by
-
A supervised network analysis on gene expression profiles of breast tumors predicts a 41-gene prognostic signature of the transcription factor MYB across molecular subtypes.Comput Math Methods Med. 2014;2014:813067. doi: 10.1155/2014/813067. Epub 2014 Feb 3. Comput Math Methods Med. 2014. PMID: 24639887 Free PMC article.
-
Microarray meta-analysis to explore abiotic stress-specific gene expression patterns in Arabidopsis.Bot Stud. 2017 Dec;58(1):22. doi: 10.1186/s40529-017-0176-8. Epub 2017 May 16. Bot Stud. 2017. PMID: 28510204 Free PMC article.
-
Identifying gene set association enrichment using the coefficient of intrinsic dependence.PLoS One. 2013;8(3):e58851. doi: 10.1371/journal.pone.0058851. Epub 2013 Mar 14. PLoS One. 2013. PMID: 23516564 Free PMC article.
-
Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis.Front Oncol. 2022 Oct 18;12:871786. doi: 10.3389/fonc.2022.871786. eCollection 2022. Front Oncol. 2022. PMID: 36330486 Free PMC article.
-
Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system.Cancer Inform. 2014 Jan 21;13:21-45. doi: 10.4137/CIN.S12493. eCollection 2014. Cancer Inform. 2014. PMID: 24526833 Free PMC article.
References
-
- Chen CJ, You SL, Lin LH, Hsu WL, Yang YW. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol. 2002;32:S66–81. - PubMed
-
- Brown M, Bauer K, Pare M. Tumor marker phenotype concordance in second primary breast cancer, California, 1999–2004. Breast Cancer Res Treat. 2010;120:217–27. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous